GoodRx Holdings Q3 Adjusted EPS $0.06, Inline, Sales $189.96M Beat $188.28M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoodRx Holdings reported Q3 earnings of $0.06 per share, meeting analyst consensus. This is a 14.29% decrease from last year. The company's quarterly sales were $189.96M, beating the analyst consensus of $188.28M by 0.89%. This is a 1.41% increase from last year.
November 09, 2023 | 11:03 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
GoodRx's Q3 earnings met expectations but decreased 14.29% YoY. Sales beat estimates by 0.89% and increased 1.41% YoY.
GoodRx's earnings met analyst expectations, which is generally positive. However, the YoY decrease in earnings could be a concern for investors. The sales beat and YoY increase is a positive sign, potentially offsetting the negative impact of the earnings decrease.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100